Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02463994
Title A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University of Michigan Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
University of Washington, Seattle Seattle Washington United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field